However, these studies are observational, not randomized trials, so we cannot yet interpret the findings as proof of a cancer risk reduction. The review also addressed the question of whether GLP-1s reduce cancer risk because they cause weight loss and improved metabolism, or because they have a direct anti-cancer effect
The gradual weight reduction typically achieved with these medications has not been associated with clinically significant changes in thrombotic risk in clinical trials
Check Eli Lillys Trial Portal Since Eli Lilly develops retatrutide, their clinical trials website provides another valuable resource
You can't evaluate whether the dose levels - even if the ingredients were named - align with the amounts studied in published research
The result is a dampened metabolic signal: blood sugar rises higher after eating, stays elevated longer, and the calming, energy-stabilizing effect of natural GLP-1 weakens